These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 8899707)

  • 1. An elongation factor Tu (EF-Tu) resistant to the EF-Tu inhibitor GE2270 in the producing organism Planobispora rosea.
    Sosio M; Amati G; Cappellano C; Sarubbi E; Monti F; Donadio S
    Mol Microbiol; 1996 Oct; 22(1):43-51. PubMed ID: 8899707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elongation factor Tu1 of the antibiotic GE2270A producer Planobispora rosea has an unexpected resistance profile against EF-Tu targeted antibiotics.
    Möhrle VG; Tieleman LN; Kraal B
    Biochem Biophys Res Commun; 1997 Jan; 230(2):320-6. PubMed ID: 9016775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural kirromycin resistance of elongation factor Tu from the kirrothricin producer Streptomyces cinnamoneus.
    Cappellano C; Monti F; Sosio M; Donadio S; Sarubbi E
    Microbiology (Reading); 1997 Feb; 143 ( Pt 2)():617-624. PubMed ID: 9043138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GE2270A-resistant mutations in elongation factor Tu allow productive aminoacyl-tRNA binding to EF-Tu.GTP.GE2270A complexes.
    Zuurmond AM; Martien de Graaf J; Olsthoorn-Tieleman LN; van Duyl BY; Mörhle VG; Jurnak F; Mesters JR; Hilgenfeld R; Kraal B
    J Mol Biol; 2000 Dec; 304(5):995-1005. PubMed ID: 11124042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Three tuf-like genes in the kirromycin producer Streptomyces ramocissimus.
    Vijgenboom E; Woudt LP; Heinstra PW; Rietveld K; van Haarlem J; van Wezel GP; Shochat S; Bosch L
    Microbiology (Reading); 1994 Apr; 140 ( Pt 4)():983-98. PubMed ID: 8012612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of bacterial protein synthesis by elongation-factor-Tu-binding antibiotics MDL 62,879 and efrotomycin.
    Landini P; Bandera M; Goldstein BP; Ripamonti F; Soffientini A; Islam K; Denaro M
    Biochem J; 1992 May; 283 ( Pt 3)(Pt 3):649-52. PubMed ID: 1590753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New antibiotic that acts specifically on the GTP-bound form of elongation factor Tu.
    Anborgh PH; Parmeggiani A
    EMBO J; 1991 Apr; 10(4):779-84. PubMed ID: 2009857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elongation factor Tu3 (EF-Tu3) from the kirromycin producer Streptomyces ramocissimus Is resistant to three classes of EF-Tu-specific inhibitors.
    Olsthoorn-Tieleman LN; Palstra RJ; van Wezel GP; Bibb MJ; Pleij CW
    J Bacteriol; 2007 May; 189(9):3581-90. PubMed ID: 17337575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Substitution of Arg230 and Arg233 in Escherichia coli elongation factor Tu strongly enhances its pulvomycin resistance.
    Boon K; Krab I; Parmeggiani A; Bosch L; Kraal B
    Eur J Biochem; 1995 Feb; 227(3):816-22. PubMed ID: 7867642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure and expression of elongation factor Tu from Bacillus stearothermophilus.
    Krásný L; Mesters JR; Tieleman LN; Kraal B; Fucík V; Hilgenfeld R; Jonák J
    J Mol Biol; 1998 Oct; 283(2):371-81. PubMed ID: 9769211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutations to kirromycin resistance occur in the interface of domains I and III of EF-Tu.GTP.
    Abdulkarim F; Liljas L; Hughes D
    FEBS Lett; 1994 Sep; 352(2):118-22. PubMed ID: 7925958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure of an EF-Tu complex with a thiazolyl peptide antibiotic determined at 2.35 A resolution: atomic basis for GE2270A inhibition of EF-Tu.
    Heffron SE; Jurnak F
    Biochemistry; 2000 Jan; 39(1):37-45. PubMed ID: 10625477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibiotic GE2270 a: a novel inhibitor of bacterial protein synthesis. I. Isolation and characterization.
    Selva E; Beretta G; Montanini N; Saddler GS; Gastaldo L; Ferrari P; Lorenzetti R; Landini P; Ripamonti F; Goldstein BP
    J Antibiot (Tokyo); 1991 Jul; 44(7):693-701. PubMed ID: 1908853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutant ribosomes can generate dominant kirromycin resistance.
    Tubulekas I; Buckingham RH; Hughes D
    J Bacteriol; 1991 Jun; 173(12):3635-43. PubMed ID: 2050625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. One-step purification of E. coli elongation factor Tu.
    Knudsen CR; Clark BF; Degn B; Wiborg O
    Biochem Int; 1992 Oct; 28(2):353-62. PubMed ID: 1456956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sensitivity of elongation factor Tu (EF-Tu) from different bacterial species to the antibiotics efrotomycin, pulvomycin and MDL 62879.
    Landini P; Bandera M; Soffientini A; Goldstein BP
    J Gen Microbiol; 1993 Apr; 139(4):769-74. PubMed ID: 8515234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The structural and functional basis for the kirromycin resistance of mutant EF-Tu species in Escherichia coli.
    Mesters JR; Zeef LA; Hilgenfeld R; de Graaf JM; Kraal B; Bosch L
    EMBO J; 1994 Oct; 13(20):4877-85. PubMed ID: 7525272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pulvomycin-resistant mutants of E.coli elongation factor Tu.
    Zeef LA; Bosch L; Anborgh PH; Cetin R; Parmeggiani A; Hilgenfeld R
    EMBO J; 1994 Nov; 13(21):5113-20. PubMed ID: 7957075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional role of the noncatalytic domains of elongation factor Tu in the interactions with ligands.
    Cetin R; Anborgh PH; Cool RH; Parmeggiani A
    Biochemistry; 1998 Jan; 37(2):486-95. PubMed ID: 9425069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EF-Tu from the enacyloxin producing Frateuria W-315 strain: Structure/activity relationship and antibiotic resistance.
    Créchet JB; Malosse C; Hountondji C
    Biochimie; 2016 Aug; 127():59-69. PubMed ID: 27126073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.